Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritisRyan Malcolm Hum, Ann Brownfield, Nisha Nair et al.|Lara D. Veeken|2022Cited by 8